Alphaform

Alphaform FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of Alphaform (AFRMF) as of Nov 11, 2026 is 148.58 %.

FCF Conversion

148.58 %

Last updated:

FCF Conversion Rate (FCF/EBITDA) of Alphaform is 2014 148.58 % . FCF Conversion Rate (FCF/EBITDA) of Alphaform was 2013 - . It decreases by % lower compared to the previous year.

The Alphaform FCF Conversion history

The Alphaform FCF Conversion history
YEARFCF ConversionYoY
148.58 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Alphaform Stock analysis

What does Alphaform do? Alphaform AG generates revenue through industrial development services and production using innovative 3D printing technologies. The company specializes in laser sintering and stereo-lithography, producing prototype parts and models from resin and plastic powder. Clients from the automobile and aerospace industries purchase these services, including modeling, finishing, coating, and metal coating. Subsidiaries like Alphaform-Claho GmbH provide additional services such as tool making and CNC milling, while Medi-Met Precision Casting and Implants Technology GmbH focuses on manufacturing semi-finished medical implants like knee and hip implants. Alphaform-Claho GmbH serves clients requiring precision tool making and CNC milling for various parts, complementing Alphaform AG's core 3D printing offerings. Medi-Met Precision Casting and Implants Technology GmbH targets the medical sector with semi-finished implants, directly serving healthcare providers and medical device manufacturers. The company’s product portfolio spans industrial prototyping, precision manufacturing, and medical implant components, all delivered through its subsidiaries and core services. The automobile and aerospace industries are key clients for Alphaform AG's 3D printed parts and related services. Alphaform-Claho GmbH supports these sectors with tool making and CNC milling capabilities, enhancing the production process for complex components. Medi-Met Precision Casting and Implants Technology GmbH caters to the medical industry, supplying semi-finished implants that require high precision and specialized manufacturing techniques. Alphaform is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Alphaform stock

FCF Conversion Rate (FCF/EBITDA) of Alphaform is 148.58 % in 2014.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) Alphaform since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s Alphaform with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Alphaform

All Key Metrics — Alphaform